796
Views
3
CrossRef citations to date
0
Altmetric
Case Report

A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency

ORCID Icon, , , , &

References

  • Weidmann H, Heikaus L, Long AT, et al. The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity. Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt B):2118–2127.
  • Renné T, Schmaier AH, Nickel KF, et al. In vivo roles of factor XII. Blood. 2012;120(22):4296–4303.
  • Schmaier AH. The elusive physiologic role of factor XII. J Clin Invest. 2008;118(9):3006–3009.
  • Müller F, Renné T. Novel roles for factor XII-driven plasma contact activation system. Curr Opin Hematol. 2008;15(5):516–521.
  • Schmaier AH, Stavrou EX. Factor XII – what's important but not commonly thought about. Res Pract Thromb Haemost. 2019;3(4):599–606.
  • Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. J Biol Chem. 1987;262(28):13662–13673.
  • Fernandes HD, Newton S, Rodrigues JM. Factor XII Deficiency Mimicking Bleeding Diathesis: a unique presentation and diagnostic pitfall. Cureus. 2018;10(6):e2817.
  • Jin P, Jiang W, Yan H, et al. Novel mutations in congenital factor XII deficiency. Front Biosci (Landmark Ed). 2016;21:419–429.
  • Schmaier AH, McCrae KR. The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost. 2007;5(12):2323–2329.
  • Worm M, Kohler E C, Panda R, et al. The factor XII a blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities. Ann Transl Med. 2015;3(17):247.
  • Travers RJ, Shenoi RA, Kalathottukaren MT, et al. Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis. Blood. 2014;124(22):3183–3190.
  • Cheng X, Yang L, Huang G, et al. Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg. Hematology. 2017;22(5):310–315.
  • Schloesser M, Zeerleder S, Lutze G, et al. Mutations in the human factor XII gene. Blood. 1997;90(10):3967–3977.
  • Hao X, Cheng X, Wang Y, et al. A novel gene insertion combined with a missense mutation causing factor VII deficiency in two unrelated Chinese families. Blood Coagul Fibrinolysis. 2015;26(6):687–690.
  • Wang Y, Zhu L, Ye L, et al. Factor V deficiency caused by a novel nonsense mutation (Gln2031stop) in a Chinese patient. Blood Coagul Fibrinolysis. 2014;25(3):283–285.
  • Zeerleder S, Schloesser M, Redondo M, et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency–a study on 73 subjects from 14 Swiss families. Thromb Haemost. 1999;82(4):1240–1246.
  • Girolami A, Ferrari S, Cosi E, et al. Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: results of a long term study. Blood Cells Mol Dis. 2019;77:8–11.
  • Girolami A, Ferrari S, Cosi E, et al. Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period. J Thromb Thrombolysis. 2019;47(3):481–485.
  • Kondo S, Tokunaga F, Kawano S, et al. Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation. Blood. 1999;93(12):4300–4308.
  • Ishii K, Oguchi S, Moriki T, et al. Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Blood Coagul Fibrinolysis. 2004;15(5):367–373.
  • Zhang H, Liu S, Lin C, et al. Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency. Hematology. 2019;24(1):420–425.